Cargando…

1724. Murine Efficacy Studies of Sulopenem Against Bacillus anthracis

BACKGROUND: Sulopenem is a thiopenem β-lactam antibiotic being developed for the treatment of infections caused by multi-drug resistant bacteria. Sulopenem is available as intravenous and oral pro-drug formulations, and its activity aligns with the most urgent drug-resistant antimicrobial threats de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Puttagunta, Sailaja, Aronin, Steven I, Dunne, Michael, Halasohoris, Stephanie A, Babyak, Ashley, Hourihan, Mary K, Meinig, James M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752655/ http://dx.doi.org/10.1093/ofid/ofac492.1354

Ejemplares similares

1393. A Phase 1, Randomized, Open-Label, Crossover Study in Healthy Subjects Under Fasting Conditions of Orally Administered Sulopenem Etzadroxil Alone or with Probenecid to Determine the Pharmacokinetics of Sulopenem
por: Dunne, Michael, et al.
Publicado: (2018)

1363. Sulopenem Activity Against Enterobacteriaceae Isolates From Patients With Urinary Tract Infection or Intra-Abdominal Infection
por: Puttagunta, Sailaja, et al.
Publicado: (2018)

2106. Desirability of Outcome Ranking (DOOR): Application to a Phase 3 Registrational Trial Evaluating Sulopenem for Patients with Complicated Intra-abdominal Infection (cIAI)
por: Aronin, Steven I, et al.
Publicado: (2023)

Sulopenem Disk Development, Quality Control Range, and MIC to Disk Result Correlation for Enterobacterales Isolates
por: Puttagunta, Sailaja, et al.
Publicado: (2023)

Sulopenem for the Treatment of Complicated Urinary Tract Infections Including Pyelonephritis: A Phase 3, Randomized Trial
por: Dunne, Michael W, et al.
Publicado: (2022)

Sulopenem or Ciprofloxacin for the Treatment of Uncomplicated Urinary Tract Infections in Women: A Phase 3, Randomized Trial
por: Dunne, Michael W, et al.
Publicado: (2022)

Applying Desirability of Outcome Ranking End Point to Randomized Trial of Sulopenem for the Treatment of Complicated Urinary Tract Infections
por: Dunne, Michael W, et al.
Publicado: (2023)

In vitro activity of sulopenem and comparator agents against Enterobacterales and anaerobic clinical isolates collected during the SENTRY Antimicrobial Surveillance Program
por: Maher, Joshua M, et al.
Publicado: (2023)

2569. Pharmacokinetic-Pharmacodynamic Evaluation of Sulopenem Using a Five-Day Hollow-Fiber In Vitro Infection Model
por: VanScoy, Brian D, et al.
Publicado: (2023)

1232. Efficacy and Safety of Intravenous Sulopenem Followed by Oral Sulopenem etzadroxil/Probenecid Versus Intravenous Ertapenem Followed by Oral Ciprofloxacin or Amoxicillin-clavulanate in the Treatment of Complicated Urinary Tract Infections (cUTI): Results from the SURE-2 Trial
por: Dunne, Michael W, et al.
Publicado: (2020)

2568. Characterization of Sulopenem Pharmacokinetics-Pharmacodynamics Using a One-Compartment In Vitro Infection Model
por: VanScoy, Brian D, et al.
Publicado: (2023)

1527. The Prevalence of Enterobacteriaceae (ENT) Resistant to All Major Classes of Oral Antibiotics from Outpatient Urine Cultures in the United States and Effect on Clinical Outcomes
por: Dunne, Michael, et al.
Publicado: (2018)

In Vitro and In Vivo Activity of Omadacycline against Two Biothreat Pathogens, Bacillus anthracis and Yersinia pestis
por: Steenbergen, Judith, et al.
Publicado: (2017)

LB-1. Efficacy and Safety of Oral Sulopenem Etzadroxil/Probenecid Versus Oral Ciprofloxacin in the Treatment of Uncomplicated Urinary Tract Infections (uUTI) in Adult Women: Results from the SURE-1 Trial
por: Dunne, Michael W, et al.
Publicado: (2020)

Impact of Empirical Antibiotic Therapy on Outcomes of Outpatient Urinary Tract Infection Due to Nonsusceptible Enterobacterales
por: Dunne, Michael W., et al.
Publicado: (2022)

Anthrax, but Not Bacillus anthracis?
por: Okinaka, Richard, et al.
Publicado: (2006)

Pyrosequencing Bacillus anthracis
por: Wahab, Tara, et al.
Publicado: (2005)

Etymologia: Bacillus anthracis
Publicado: (2014)

Preparation and Evaluation of Human-Murine Chimeric Antibody against Protective Antigen of Bacillus anthracis
por: Hao, Lina, et al.
Publicado: (2014)

Piéces de clavecin (1724) Nouvelles suites de piéces de clavecin (1728) /
por: Rameau, Jean Philippe, 1683-1764
Publicado: (1999)

Decontamination Efficacy and Skin Toxicity of Two Decontaminants against Bacillus anthracis
por: Stratilo, Chad W., et al.
Publicado: (2015)

1572. Combination Cefuroxime and Sulopenem is active in vitro against Mycobacterium abscessus
por: Dousa, Khalid M, et al.
Publicado: (2020)

Révoltes des Indiens Tarahumars (1626-1724) Joseph Neumann
por: Neumann, Joseph, 1648-1732
Publicado: (1969)

Potential distributions of Bacillus anthracis and Bacillus cereus biovar anthracis causing anthrax in Africa
por: Romero-Alvarez, Daniel, et al.
Publicado: (2020)

TaqMan Assays for Simultaneous Detection of Bacillus anthracis and Bacillus cereus biovar anthracis
por: Zincke, Diansy, et al.
Publicado: (2020)

Ruling Out Bacillus anthracis
por: Papaparaskevas, Joseph, et al.
Publicado: (2004)

Meningitis Due to Bacillus Anthracis
por: Gürcan, Şaban, et al.
Publicado: (2005)

Inactivation of Bacillus anthracis Spores
por: Whitney, Ellen A. Spotts, et al.
Publicado: (2003)

267 Dalbavancin for the treatment of Streptococcal Skin Infections
por: Puttagunta, Sailaja, et al.
Publicado: (2014)

Efficacy of Treatment with the Antibiotic Novobiocin against Infection with Bacillus anthracis or Burkholderia pseudomallei
por: Klimko, Christopher P., et al.
Publicado: (2022)

Applying Desirability of Outcome Ranking End Points
por: Dunne, Michael W, et al.
Publicado: (2023)

Allelic Variation on Murine Chromosome 11 Modifies Host Inflammatory Responses and Resistance to Bacillus anthracis
por: Terra, Jill K., et al.
Publicado: (2011)

Environmental Persistence of Bacillus anthracis and Bacillus subtilis Spores
por: Wood, Joseph P., et al.
Publicado: (2015)

1208. Omadacycline In Vitro Activity Against Bacillus Anthracis
por: Serio, Alisa W, et al.
Publicado: (2021)

Human Neutrophils Kill Bacillus anthracis
por: Mayer-Scholl, Anne, et al.
Publicado: (2005)

Characterization of the Sortase Repertoire in Bacillus anthracis
por: Aucher, Willy, et al.
Publicado: (2011)

Environmental Sampling for Spores of Bacillus anthracis
por: Teshale, Eyasu H., et al.
Publicado: (2002)

Bacillus anthracis Factors for Phagosomal Escape
por: Tonello, Fiorella, et al.
Publicado: (2012)

Characterization of Bacillus anthracis Persistence In Vivo
por: Jenkins, Sarah A., et al.
Publicado: (2013)

Detection of Bacillus anthracis and Bacillus anthracis-like spores in soil from state of Rio de Janeiro, Brazil
por: Salgado, Jacqueline RS, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t84apnohv0b0tm33a6i9r9rbon